Table 4.
Studies on pure neuritic leprosy
| Studies | Number of pure neuritic leprosy cases | Percentage of pure neuritic cases | Most common age group (years) | Male to female ratio | Most common presentation | Percentage of patients with grade 2 disability at the time of presentation | Appearance of skin lesions while on treatment or during follow-up period |
|---|---|---|---|---|---|---|---|
| Narang et al. | 48 | 5.3 | Below 30 | 5.9:1 | Mononeuritis multiplex | 66.6 | - |
| *Kumar et al. | 65 | 4.2 | 15-35 | 2.6:1 | Mononeuritis multiplex | - | None |
| Mendiratta et al. | 32 | 4.6 | 15-30 | 9.7:1 | Mononeuritis multiplex | 50 | - |
| †Talwar et al. | 42 | 10.7 | - | - | Mononeuritis | - | Three patients |
| ‡Present study | 75 | 8.5 | 41-60 | 3.7:1 | Mononeuritis multiplex | 80 | None |
* Kumar et al.: Two-year follow up was available in only 32/65 patients (49.2%) and none of them developed skin lesions during this period.
† Talwar et al.: The study also included data on 20 cases of pure neuritic leprosy managed with dapsone monotherapy; the information on only those patients who received multidrug therapy (paucibacillary type) are shown in the table.
‡ Present study = 1-year follow up was available in 46 patients and none of them developed skin lesions during this period